U.S.-China Technology War: Sinopharm Holdings Subsidiary CSCI Listed by U.S. Entities

Sinopharm Holdings (01099) announced that its subsidiary, China Science Equipment, was placed on the entity list by the U.S. Department of Commerce. According to the decision, Sinopharm requires prior permission from the U.S. Department of Commerce for the export, re-export and domestic transfer of items regulated by U.S. export control regulations. CSCI accounted for 3.9% of the Group’s audited consolidated pre-tax profit. The Company is conducting a comprehensive assessment of the potential impact of the decision.